A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT07153796 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07153796
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2031-09-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.